COVID-19 CIDRAP Viewpoint Reports
Part 1: The Future of the COVID-19 Pandemic: Lessons Learned from Pandemic Influenza
Kristine A. Moore, MD, MPH; Marc Lipsitch, DPhil; John M. Barry, MA; Michael T. Osterholm, PhD, MPH
April 30, 2020
Part 2: Effective COVID-19 Crisis Communication
Peter M. Sandman, PhD; Jody Lanard, MD
May 6, 2020
Part 3: Smart Testing for COVID-19 Virus and Antibodies
Angela Ulrich, PhD, MPH; Joanne Bartkus, PhD; Kristine A. Moore, MD, MPH; Glen Hansen, PhD; Mark J. Mathieson, MBA; Michael T. Osterholm, PhD, MPH
May 20, 2020
Part 4: Contact Tracing for COVID-19: Assessing Needs, Using a Tailored Approach
Kristine Moore, MD, MPH; Jill DeBoer, MPH; Richard Hoffman, MD, MPH; Patrick McConnon, MPH; Dale Morse, MD, MS; Michael Osterholm, PhD, MPH
Reviewed by Jeffery Duchin, MD
June 2, 2020
Part 5: SARS-CoV-2 Infection and COVID-19 Surveillance: a National Framework
Angela Ulrich, PhD, MPH; Kristine Moore, MD, MPH; Cory Anderson, MPH; Julie Ostrowsky, MSc; Edward A. Belongia, MD; Ruth Berkelman, MD; Mitchell Cohen, MD; Jeffery Duchin, MD; Craig Hedberg, PhD, MS; Richard Hoffman, MD, MPH; Dale Morse, MD, MS; Michael Osterholm, PhD, MPH
July 9, 2020
Part 6: Ensuring a Resilient US Prescription Drug Supply
Stephen W. Schondelmeyer, PharmD, PhD, MPubAdm; James Seifert, JD, MPH, MS; David J. Margraf, PharmD, MS; Melissa Mueller, MPH; Ian Williamson, MBA; Chris Dickson; Divya Dasararaju, MS; Claire Caschetta; Nicholas Senne; Michael T. Osterholm, PhD, MPH
October 21, 2020
Part 7: Reassessing COVID-19 Vaccine Deployment in Anticipation of a US B.1.1.7 Surge: Stay the Course or Pivot?
Michael Osterholm, PhD, MPH; Angela Ulrich, PhD, MPH; Cory Anderson, MPH; Eric Topol, MD; Bruce Gellin, MD, MPH; Ruth Berkelman, MD; Marc Lipsitch, DPhil; Kristine Moore, MD, MPH
February 23, 2021
Our underwriters
Unrestricted financial support provided by

Supporting Underwriter